StockDriftsStockDriftsVaxcell Bio (323990) has 6 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩73M ($51K) in reported transaction value. The earliest filing StockDrifts holds for Vaxcell Bio is dated 2024-02-14; the most recent is 2026-03-25. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -10.71%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-25 | BUY | Market Buy | 이제중 Lee Je-jung | CEO | 1.0K | ₩8,150 | -1.7% | ₩8M ($6K) |
| 2026-03-25 | BUY | Market Buy | 정성창 Seongchang Jeong | vice president | 1.0K | ₩8,150 | -1.7% | ₩8M ($6K) |
| 2026-01-02 | BUY | 신규등록 | 김상기 Kim Sang-ki | Managing Director | 1.9K | ₩10,020 | -2.2% | ₩19M ($13K) |
| 2026-01-02 | BUY | 신규등록 | 김경근 Gyeonggeun Kim | Managing Director | 1.1K | ₩10,020 | -2.2% | ₩11M ($8K) |
| 2026-01-02 | BUY | 신규등록 | 서민수 Seo Min-su | Managing Director | 400 | ₩10,020 | -2.2% | ₩4M ($3K) |
| 2025-04-08 | BUY | 합병 | 이정민 Jeongmin Lee | Managing Director | 192.5K | ₩7,740 | +26.6% | ₩1.5B ($1.0M) |
| 2025-03-06 | BUY | Market Buy | 정성창 Seongchang Jeong | vice president | 1.0K | ₩8,690 | +12.8% | ₩9M ($6K) |
| 2025-03-06 | BUY | Market Buy | 이제중 Lee Je-jung | CEO | 1.5K | ₩8,690 | +12.8% | ₩13M ($9K) |
| 2024-10-18 | SELL | 증여 | 이제중 Lee Je-jung | CEO | -150.0K | ₩13,580 | +27.8% | ₩2.0B ($1.4M) |
| 2024-05-20 | BUY | Market Buy | 이제중 Lee Je-jung | CEO | 1.0K | ₩19,050 | -48.6% | ₩19M ($13K) |
| 2024-04-26 | BUY | Market Buy | 정성창 Seongchang Jeong | Internal director | 1.0K | ₩15,750 | -37.8% | ₩16M ($11K) |
| 2024-02-28 | SELL | 증여 | 이준행 Junhaeng Lee | Internal director | -8.0K | ₩19,950 | +50.9% | ₩160M ($111K) |
| 2024-02-14 | SELL | 증여 | 이준행 Junhaeng Lee | Internal director | -124.4K | ₩19,310 | +49.3% | ₩2.4B ($1.7M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Vaxcell Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.